US Patent Issued to Humanwell Pharmaceutical US, Yichang Humanwell Pharmaceutical on Dec. 30 for "Pharmaceutical formulations containing Nalbuphine" (Missouri Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,259, issued on Dec. 30, was assigned to Humanwell Pharmaceutical US Inc. (Ballwin, Mo.) and Yichang Humanwell Pharmaceutical Co. Ltd. (Yichang, China).

"Pharmaceutical formulations containing Nalbuphine" was invented by Xueming Wu (Ballwin, Mo.), Jun Yang (Ballwin, Mo.), Baohua Yue (Ballwin, Mo.), Renhe Qiu (Ballwin, Mo.) and Hong Du (Ballwin, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are new pharmaceutical formulations, their preparation, and their use for pain treatment. In particular, described herein are pharmaceutical formulations of the analgesic drug Nalbuphine for intranasal administration."

The patent was filed on...